Huadong Medicine debuts with $150m loan

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Huadong Medicine debuts with $150m loan

Pan Yue
March 02, 2021 09:30 am
Covid_lab_575px_Adobe_8June20
multiexposure background of china coronavirus COVID-19 infected blood sample in sample tube with DNA strain | Mongkolchon Akesin/Mongkolchon - stock.adobe.com

China’s Huadong Medicine Co has turned to the loan market for the first time.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansHealth and BiotechChinaAsiaGreater ChinaStandard CharteredNortheast AsiaLoans and High YieldAsia PacificLevFinLeveraged LoansEmerging Market LoansLevFin Leveraged LoansEmerging MarketsSRI
PY
Pan Yue
Loans reporter GlobalCapital Asia
Contact
Gift this article